Active Ingredient History

NOW
  • Now
Fenofibrate, is an oral medication of the fibrate class used to treat abnormal blood lipid levels. It is less commonly used compared than statins because it treats a different type of cholesterol abnormality to statins. While statins have strong evidence for reducing heart disease and death, there is evidence to suggest that fenofibrate also reduces to the risk of heart disease and death. However, this seems only to apply to specific populations of people with elevated triglyceride levels and reduced high-density lipoprotein (HDL) cholesterol. Its use is recommended together with dietary changes.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0001 - $18.1331

Australia

$0.1415 - $0.4243
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid | 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid 1-methylethyl ester | 2-(4-(4-chlorophenoxy)phenoxy)propanoic acid | 2-(4-(4'-chlorophenoxy)phenoxy)propionic acid | abt335 | abt 335 | abt-335 | antara | choline fenofibrate | choline ion | clorofibrate | fenobrate | fenocor-67 | fenofibrate | fenofibrate / pravastatin | fenofibrate / simvastatin | fenofibrato | fenofibratum | fenofibric acid | fenofibric acid potassium salt | fenofibric acid, (r)-isomer | fenofibric acid sodium salt | fenogal | fenoglide | fibricor | finofibrate | fnf | hcg 004 | isopropyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropionate | isopropyl (4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl)propionate | lipanthyl | lipantil | lipantil micro 200 | lipantil micro 267 | lipantil micro 67 | lipidil | lipidil supra | lipofen | lipofene | lofibra | procetofen | procetofene | procetofenic acid | supralip | supralip 160 | tricor | triglide | trilipix

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue